Discover 998 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 998
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
for
Clonal Cytopenia of Undetermined Significance,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT03418038
Phase2, Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Assessing the Effect of Computer-based Auditory Training on Adult Cochlear Implant Speech and Quality-of-life Outcomes
for
Cochlear Implants, Bilateral Sensorineural Hearing Loss
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06607146
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
for
Oligometastatic Prostate Cancer (OMPC)
Location: Rochester MN, Des Moines IA, Omaha NE, Elk Grove IL,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT05939414
Phase3, Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
for
Metastatic Colorectal Carcinoma,
Location: Rochester MN, Minneapolis MN, Madison WI, Chicago IL,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT05863195
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
for
Breast Neoplasm
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: Female
Age: 18+
Code: NCT06058650
Recruiting
Mechanisms of Anabolic Resistance in Older Humans
for
Aging
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 21 - 70+
Code: NCT06617195
Recruiting
Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)
for
Primary Hyperoxaluria Type 1 (PH1)
Location: Rochester MN
Sponsor: Arbor Biotechnologies
Sex: All
Age: 6 - 64
Code: NCT06839235
Phase1, Phase2, Recruiting
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
for
Autosomal Recessive Polycystic Kidney (ARPKD)
Location: Rochester MN, Ann Arbor MI, Cincinnati OH, Cleveland OH,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 0 - 18
Code: NCT04782258
Phase3, Recruiting
A Study of Pyridostigmine in Postural Tachycardia Syndrome
for
Postural Tachycardia Syndrome
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 15 - 55
Code: NCT00409435
Phase2, Recruiting
A Comparison of Neuromuscular Recruitment in Trained and Untrained Adults
for
Healthy, Insulin Resistance
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 60 - 70+
Code: NCT06820658
Recruiting
Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension
for
Resistant Hypertension
Location: Rochester MN, Detroit MI, Atlanta GA, Gainesville FL,
Sponsor: DeepQure Inc.
Sex: All
Age: 22 - 70+
Code: NCT06526858
Recruiting
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Location: Rochester MN, Madison WI, Evanston IL, Bloomington IN,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70+
Code: NCT05237258
Recruiting
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
for
Small Cell Lung Carcinoma, Neuroendocrine Neoplasms,
Location: Rochester MN, Lexington KY, Baltimore MD, Richmond VA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT05882058
Phase2, Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Rochester MN, Madison WI, Waukee IA, Omaha NE,